Novo Holdings Leads $50M Series F Extension in Route 92 Medical
September 23, 2024
Novo Holdings led a $50 million investment in Route 92 Medical as a Series F extension, joining returning investors U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and The Vertical Group. The financing will accelerate global commercialization of Route 92's neurovascular intervention product portfolio and support regulatory authorizations in new geographies; Novo Holdings' Noel Jee will join Route 92's board.
- Buyers
- Novo Holdings, U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, The Vertical Group
- Targets
- Route 92 Medical
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.